Cargando…

Treatment of cardiogenic shock with left ventricular assist device combined with cardiac resynchronization therapy: A case report

Cardiogenic shock has a poor prognosis with established treatment strategies. We report a 62 years old man with heart failure exacerbating into refractory cardiogenic shock successfully treated with the combination of a percutaneous left ventricular assist device (LVAD) and subacute cardiac resynchr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keilegavlen, Håvard, Nordrehaug, Jan Erik, Faerestrand, Svein, Fanebust, Rune, Pettersen, Reidar, Haaverstad, Rune, Tuseth, Vegard
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909952/ https://www.ncbi.nlm.nih.gov/pubmed/20598121 http://dx.doi.org/10.1186/1749-8090-5-54

Ejemplares similares

Performance of an active fixation bipolar left ventricular lead vs passive fixation quadripolar leads in cardiac resynchronization therapy, a randomized trial
por: Keilegavlen, Havard, et al.
Publicado: (2020)

Techniques for identification of left ventricular asynchrony for cardiac resynchronization therapy in heart failure
por: Schuster, Peter, et al.
Publicado: (2005)

Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non–Left Ventricular Assist Device Centers
por: Wang, Joseph I., et al.
Publicado: (2020)

Successful Management of Pheochromocytoma Crisis with Cardiogenic Shock by Percutaneous Left Ventricular Assist Device
por: Nakamura, Makiko, et al.
Publicado: (2022)

Cardiogenic shock associated with loco-regional anesthesia rescued with left ventricular assist device implantation
por: Samuels, Louis E, et al.
Publicado: (2010)

Recurrent Stress-Induced Cardiomyopathy With Cardiogenic Shock Requiring Impella Left Ventricular Assist Device
por: Feghaly, Julien, et al.
Publicado: (2021)

Outcome of patients with non‐ischaemic cardiogenic shock supported by percutaneous left ventricular assist device
por: Haurand, Jean M., et al.
Publicado: (2021)

First experience of magnetically levitated extracorporeal left ventricular assist device for cardiogenic shock in China
por: Li, Ping, et al.
Publicado: (2022)

Microaxial Left Ventricular Assist Device in Cardiogenic Shock: A Systematic Review and Meta-Analysis
por: Tan, Shien Ru, et al.
Publicado: (2022)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Right Ventricular Pacing and Sensing Function in High Posterior Septal and Apical Lead Placement in Cardiac Resynchronization Therapy
por: Kristiansen, HM, et al.
Publicado: (2012)

Cardiac Resynchronization Therapy in Cardiogenic Shock: A Case-Based Discussion
por: Somoza-Cano, Francisco J, et al.
Publicado: (2021)

Temporary Mechanical Circulatory Support for Refractory Cardiogenic Shock Before Left Ventricular Assist Device Surgery
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2018)

Commentary: Why should we classify damage control in cardiac surgery?
por: Haaverstad, Rune, et al.
Publicado: (2021)

Cardiac Resynchronization Therapy Device Implantation in a Patient with Cardiogenic Shock under Percutaneous Mechanical Circulatory Support
por: Lim, Kyunghee, et al.
Publicado: (2017)

Self-reported health status, treatment decision and survival in asymptomatic and symptomatic patients with aortic stenosis in a Western Norway population undergoing conservative treatment: a cross-sectional study with 18 months follow-up
por: Oterhals, Kjersti, et al.
Publicado: (2017)

Haemodynamic efficacy of microaxial left ventricular assist device in cardiogenic shock: a systematic review and meta-analysis
por: van Dort, D. I. M., et al.
Publicado: (2019)

IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
por: Schurtz, Guillaume, et al.
Publicado: (2021)

Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2021)

Outcome of Extracorporeal Ventricular Assist Device for Cardiogenic Shock as a Bridge to Transplantation
por: Kim, Hyo-Hyun, et al.
Publicado: (2020)

Combined etiology of anaphylactic cardiogenic shock: Amiodarone, epinephrine, cardioverter defibrillator, left ventricular assist devices and the Kounis syndrome
por: Kounis, Nicholas G., et al.
Publicado: (2015)

A dual therapy of off-pump temporary left ventricular extracorporeal device and amniotic stem cell for cardiogenic shock
por: Kazui, Toshinobu, et al.
Publicado: (2017)

Percutaneous Left Ventricular Assist Device in Cardiogenic Shock: A Five-Year Single Canadian Center Initial Experience
por: Trpkov, Cvetan, et al.
Publicado: (2020)

Surgical outcomes of bridge-to-bridge therapy with extracorporeal left ventricular assist device for acute myocardial infarction in cardiogenic shock
por: Tokunaga, Chiho, et al.
Publicado: (2022)

Predictive value of the APACHE II score in cardiogenic shock patients treated with a percutaneous left ventricular assist device
por: Mierke, Johannes, et al.
Publicado: (2022)

Dynamic left ventricular outflow tract obstruction in Takotsubo cardiomyopathy resulting in cardiogenic shock
por: Conradi, Paulina M, et al.
Publicado: (2021)

Cardiogenic Shock due to Psychosis-Induced Inverted Takotsubo Cardiomyopathy Bridged-to-Recovery with a Percutaneous Left Ventricular Assist Device
por: Korabathina, Ravi, et al.
Publicado: (2016)

A case of cardiogenic shock due to acute coronary syndrome successfully recovered by percutaneous and paracorporeal left ventricular assist device
por: Nakamura, Makiko, et al.
Publicado: (2019)

Data for validation and adjustment of APACHE II score in cardiogenic shock patients treated with a percutaneous left ventricular assist device
por: Mierke, Johannes, et al.
Publicado: (2022)

Opposing forces of cardiogenic shock: left ventricular outflow obstruction, severe mitral regurgitation, and left ventricular dysfunction in Takotsubo cardiomyopathy
por: Methvin, Laura, et al.
Publicado: (2022)

Complications from percutaneous-left ventricular assist devices versus intra-aortic balloon pump in acute myocardial infarction-cardiogenic shock
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2020)

Successful treatment of cardiogenic shock due to Takotsubo syndrome with implantation of a temporary microaxial left ventricular assist device in transaxillary approach
por: von Mackensen, Johanna K. R., et al.
Publicado: (2023)

Impella Use in Cardiogenic Shock Due to Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction
por: Mohammedzein, Assad, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients
por: Gopinathannair, Rakesh, et al.
Publicado: (2018)

Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation
por: Roukoz, Henri, et al.
Publicado: (2020)

The “TIDE”-Algorithm for the Weaning of Patients With Cardiogenic Shock and Temporarily Mechanical Left Ventricular Support With Impella Devices. A Cardiovascular Physiology-Based Approach
por: Tschöpe, Carsten, et al.
Publicado: (2021)

Is right ventricular resynchronization the key to both right and left ventricular remodeling?
por: Markel, Franziska, et al.
Publicado: (2019)

Central extracorporeal life support with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure
por: Weymann, Alexander, et al.
Publicado: (2014)

Streptococcus constellatus Left Ventricular Apical Mural Infective Endocarditis With Acute Stroke, Septic and Cardiogenic Shock
por: Hilker, Eric, et al.
Publicado: (2022)

Short-term assist devices in postcardiotomy cardiogenic shock
por: Iner, Hasan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qqf6uq9fho4i365j568hvmc5bt